11 Jun 2020
Indian generic pharma manufacturers poised to produce APIs for COVID-19 drugs
By Staff Writer
Local production of active pharmaceutical ingredients for some key COVID-19 repurposed drugs is likely to offer a competitive advantage for the formulations manufactured in India in terms of supply and price. This according to data and analytics company, GlobalData. According to GlobalData’s COVID-19 Executive Briefing, COVID-19 has spread to 189 countries with over 6 million...
